The Firm recently represented the underwriters, led by Barclays Capital Inc., Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC, in connection with the public offering by CVS Health Corporation of $4 billion of senior notes, consisting of $750 million of 3.625% senior notes due 2027, $1.5 billion of 3.75% senior notes due 2030, $1 billion of 4.125% senior notes due 2040 and $750 million of 4.25% senior notes due 2050. The offering closed March 31, 2020.
CVS Health is the nation’s premier health innovation company. CVS Health has approximately 9,900 retail locations, approximately 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 105 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year and expanding specialty pharmacy services. CVS Health also serves an estimated 37 million people through traditional, voluntary and consumer-directed health insurance products and related services, including rapidly expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan.
The Simpson Thacher team for the transactions included Roxane Reardon, Ryan Bekkerus, Stephanie Rowan and Adriana Estor-Restrepo (Capital Markets); Jonathan Cantor (Tax); Michael R. Isby (Environmental); Melanie Jolson (Intellectual Property); and Jennie Getsin (FINRA and Blue Sky).